(Press-News.org) Opioids – strong morphine-based painkillers – are widely prescribed to patients experiencing chronic severe pain. While these drugs are very effective for treating and managing pain, they have one particularly bothersome side effect: constipation. A new drug, called naloxegol, could bring relief. In stage 3 trials reported in the New England Journal of Medicine, KU Leuven and international researchers provide new evidence that the drug relieves constipation without dulling opioids' pain-relieving effects.
Up until a decade ago, physicians rarely prescribed opioids, reserving them primarily for the terminally sick. Today, opioid-based drugs have proliferated thanks to their 'user-friendliness' and effectiveness. Millions of patients take opioids on a daily basis to manage lower back pain and chronic joint problems. Opioids also play a critical role in pain management regimes for cancer patients.
However, opioids have a number of side effects, including nausea, vomiting and – notoriously – constipation. Opioids block pain by binding to 'mu-receptors' in the brain. But they also bind to mu-receptors in the bowels, and this causes constipation.
Some sixty percent of patients that take opioid pain relievers experience constipation. For some, the bother is so great that they choose to stop taking the drug.
A newly developed opioid antagonist called naloxegol may offer relief. Stage 3 testing by an international team of researchers led by Belgian gastroenterologist Jan Tack (University Hospitals Leuven) confirms the drug's efficacy.
Naloxegol is based on the same active molecule as naloxone, a drug developed in the 1960s to counter the effects of opioid overdose. Naloxone is commonly used to wake patients from opioid-induced anesthesia after surgery.
To arrive at naloxegol, the researchers modified the molecular structure of naloxone. The result is an orally administered, once-a-day pill for patients experiencing opioid-induced constipation.
The researchers tested the pill's efficacy in two phase 3 studies – with promising results. Naloxegol was shown to maintain opioids' pain-killing effect in the brain and block their effects in the bowels. Bowel function in all of the 1,400 test subjects returned to normal and accompanying stomach pain and other discomforts decreased. No patients experienced a diminished pain-relieving effect as a result of the drug.
While the studies addressed in the paper focused on patients taking opioids for non-cancer pain such as back pain and other musculoskeletal ailments, similar studies are now underway to examine the effect of naloxegol in patients with chronic cancer-related pain.
Final regulatory approval for the drug is pending in the United States and Europe.
INFORMATION:
Promising medication counteracts constipation caused by opioid painkillers
Once-a-day pill could flush out bothersome side effect for many patients taking opioids like Vicodin, OxyContin and Percocet
2014-07-16
ELSE PRESS RELEASES FROM THIS DATE:
Bubble wrap serves as sheet of tiny test tubes in resource-limited regions
2014-07-16
Popping the blisters on the bubble wrap might be the most enjoyable thing about moving. But now, scientists propose a more productive way to reuse the popular packing material — as a sheet of small, test tube-like containers for medical and environmental samples. Their report, which shows that analyses can take place right in the bubbles, appears in the ACS journal Analytical Chemistry.
George Whitesides and colleagues explain that although bubble wrap filled with biological samples, like blood or urine, or chemicals would have to be handled carefully, the material offers ...
NIH turns to crowdsourcing to repurpose drugs
2014-07-16
New Rochelle, NY, July 16, 2014–Experimental drugs proven safe but perhaps not sufficiently effective in initial testing or against a first disease target may sit gathering dust on the shelves of pharmaceutical companies. An NIH-sponsored effort based on a crowdsourcing strategy to establish collaborations between industrial and academic partners to test and develop these therapeutic compounds was met with an overwhelming response and has led to clinical testing of a broad range of pilot projects and a newly announced round of funding opportunities. These findings are described ...
What do Google searches tell us about our climate change fears?
2014-07-16
Republicans search the Net for information about the weather, climate change and global warming during extremely hot or cold spells. Democrats Google these terms when they experience changes in the average temperatures. These are some of the surprising findings from a study by Corey Lang of the University of Rhode Island in the US, published in Springer's journal Climatic Change. He tracked how the temperature fluctuations and rainfall that Americans experience daily in their own cities make them scour the Internet in search of information about climate change and global ...
An anti-glare, anti-reflective display for mobile devices?
2014-07-16
If you've ever tried to watch a video on a tablet on a sunny day, you know you have to tilt it at just the right angle to get rid of glare or invest in a special filter. But now scientists are reporting in the journal ACS Applied Materials & Interfaces that they've developed a novel glass surface that reduces both glare and reflection, which continue to plague even the best mobile displays today.
Valerio Pruneri and colleagues note that much effort has been poured into anti-reflective and anti-glare technology. In the highly competitive digital age, any bonus feature ...
Fundamental research is paving the way for development of first vaccine for heart disease
2014-07-16
DETROIT — Researchers at Wayne State University have made a fundamental discovery and, in subsequent collaboration with scientists at La Jolla Institute for Allergy and Immunology (LIAI), are one step closer to the goal of developing the world's first T-cell peptide-based vaccine for heart disease — the number one killer in the nation.
Atherosclerosis is a chronic inflammatory disease of the arterial walls, which thicken due to accumulation of fatty materials such as cholesterols and triglycerides. Blocking of arteries supplying blood to the heart is the underlying cause ...
Decoding dengue
2014-07-16
Scientists have discovered a new pathway the dengue virus takes to suppress the human immune system. This new knowledge deepens our understanding of the virus and could contribute to the development of more effective therapeutics.
For years, the conventional approach to target the dengue virus was through vector control, which was regarded to be the most effective method. This is because the mechanics of the virus have been elusive, which in turn hampered the development of effective treatments and vaccines.
Fortunately a new study, published in the prestigious journal ...
Aqueous two-phase systems enable multiplexing of homogeneous immunoassays
2014-07-16
A new protein biomarker test platform developed by researchers at the University of Michigan and Indiana University promises to improve diagnostic testing. The test can accurately and simultaneously measure multiple proteins that indicate the presence of diseases like graft-versus-host disease (bone marrow transplant rejection) in only two hours, no washing steps, and using only a minute volume of blood plasma. A report on this new technology can be found online in the journal TECHNOLOGY.
The protein test uses a micropatterning method developed in Shuichi Takayama's Micro/Nano/Molecular ...
Tracking the breakup of Arctic summer sea ice
2014-07-16
As sea ice begins to melt back toward its late September minimum, it is being watched as never before. Scientists have put sensors on and under ice in the Beaufort Sea for an unprecedented campaign to monitor the summer melt.
The international effort hopes to figure out the physics of the ice edge in order to better understand and predict open water in Arctic seas.
"This has never been done at this level, over such a large area and for such a long period of time," said principal investigator Craig Lee, an oceanographer at the University of Washington's Applied Physics ...
Breast cancer: DMP is largely consistent with guidelines
2014-07-16
On 16 July 2014 the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with breast cancer. The aim of the report is to identify those recommendations from current guidelines of high methodological quality that may be relevant for the planned revision of the disease management programme (DMP). According to the results of the report, there is no compelling need for revision of any part of the DMP. However, IQWiG identified some aspects that ...
Self-assembling nanoparticle could improve MRI scanning for cancer diagnosis
2014-07-16
Scientists have designed a new self-assembling nanoparticle that targets tumours, to help doctors diagnose cancer earlier.
The new nanoparticle, developed by researchers at Imperial College London, boosts the effectiveness of Magnetic Resonance Imaging (MRI) scanning by specifically seeking out receptors that are found in cancerous cells.
The nanoparticle is coated with a special protein, which looks for specific signals given off by tumours, and when it finds a tumour it begins to interact with the cancerous cells. This interaction strips off the protein coating, ...
LAST 30 PRESS RELEASES:
Premenstrual symptoms linked to increased risk of cardiovascular disease
Newly discovered remains of ancient river landscapes control ice flow in East Antarctica
Newly discovered interstellar object 'may be oldest comet ever seen'
Animal-inspired AI robot learns to navigate unfamiliar terrain
Underserved youth less likely to visit emergency department for concussion in Ontario, study finds
‘Molecular shield’ placed in the nose may soon treat common hay fever trigger
Beetles under climate stress lay larger male eggs: Wolbachia infection drives adaptive reproduction strategy in response to rising temperature and CO₂
Groundbreaking quantum study puts wave-particle duality to work
Weekly injection could be life changing for Parkinson’s patients
Toxic metals linked to impaired growth in infants in Guatemala
Being consistently physically active in adulthood linked to 30–40% lower risk of death
Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks
Children’s social care involvement common to nearly third of UK mums who died during perinatal period
‘Support, not judgement’: Study explores links between children’s social care involvement and maternal deaths
Ethnic minority and poorer children more likely to die in intensive care
Major progress in fertility preservation after treatment for cancer of the lymphatic system
Fewer complications after additional ultrasound in pregnant women who feel less fetal movement
Environmental impact of common pesticides seriously underestimated
The Milky Way could be teeming with more satellite galaxies than previously thought
New study reveals surprising reproductive secrets of a cricket-hunting parasitoid fly
Media Tip Sheet: Symposia at ESA2025
NSF CAREER Award will power UVA engineer’s research to improve drug purification
Tiny parasitoid flies show how early-life competition shapes adult success
New coating for glass promises energy-saving windows
Green spaces boost children’s cognitive skills and strengthen family well-being
Ancient trees dying faster than expected in Eastern Oregon
Study findings help hone precision of proven CVD risk tool
Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later
Introducing BioEmu: A generative AI Model that enables high-speed and accurate prediction of protein structural ensembles
Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans
[Press-News.org] Promising medication counteracts constipation caused by opioid painkillersOnce-a-day pill could flush out bothersome side effect for many patients taking opioids like Vicodin, OxyContin and Percocet